AU6767300A - Cancer treatments and diagnostics utilizing rad51 related molecules and methods - Google Patents

Cancer treatments and diagnostics utilizing rad51 related molecules and methods

Info

Publication number: AU6767300A
Authority: AU; Australia
Prior art keywords: methods; related molecules; cancer treatments; rad51; diagnostics utilizing
Prior art date: 1999-08-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU67673/00A

Inventor

Gurucharan Reddy

Horst-Werner Sturzbecher

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pangene Corp

Original Assignee

Pangene Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-10

Filing date

2000-08-10

Publication date

2001-03-05

1999-12-06 Priority claimed from US09/454,495 external-priority patent/US6576759B2/en

2000-08-10 Application filed by Pangene Corp filed Critical Pangene Corp

2001-03-05 Publication of AU6767300A publication Critical patent/AU6767300A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Marine Sciences & Fisheries (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)

AU67673/00A 1999-08-10 2000-08-10 Cancer treatments and diagnostics utilizing rad51 related molecules and methods Abandoned AU6767300A (en)

Applications Claiming Priority (11)

Application Number	Priority Date	Filing Date	Title
US14809299P	1999-08-10	1999-08-10
US14809199P	1999-08-10	1999-08-10
US60148092		1999-08-10
US60148091		1999-08-10
US15461699P	1999-09-17	1999-09-17
US60154616		1999-09-17
US45530099A	1999-12-06	1999-12-06
US09454495		1999-12-06
US09455300		1999-12-06
US09/454,495 US6576759B2 (en)	1999-02-10	1999-12-06	Antisense inhibition of RAD51
PCT/US2000/022077 WO2001011369A1 (en)	1999-08-10	2000-08-10	Cancer treatments and diagnostics utilizing rad51 related molecules and methods

Publications (1)

Publication Number	Publication Date
AU6767300A true AU6767300A (en)	2001-03-05

Family

ID=27538317

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU67673/00A Abandoned AU6767300A (en)	1999-08-10	2000-08-10	Cancer treatments and diagnostics utilizing rad51 related molecules and methods

Country Status (5)

Country	Link
EP (1)	EP1204868A1 (en)
JP (1)	JP2003506100A (en)
AU (1)	AU6767300A (en)
CA (1)	CA2379608A1 (en)
WO (1)	WO2001011369A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001283226A1 (en) *	2001-08-09	2003-02-24	Pangene Corporation	Methods and compositions for inhibiting rad51
RU2446796C2 (en)	2006-12-26	2012-04-10	Фармасайкликс, Инк.	Method for using histone deacetylase and biomarker monitoring in combined therapy
WO2008156827A2 (en) *	2007-06-20	2008-12-24	Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Molecular grading methods for ductal carcinoma in situ
US8188252B2 (en) *	2008-11-17	2012-05-29	University Of Rochester	Rad51 derived cancer cell specific promoters for targeted anti-cancer therapy
KR101892788B1 (en)	2011-09-13	2018-08-28	파마싸이클릭스 엘엘씨	Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
CA2909383C (en)	2012-04-12	2020-11-10	University Of Saskatchewan	Phthalocyanine compounds useful as reca inhibitors and methods of using same
EP3502700A1 (en) *	2017-12-21	2019-06-26	Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron	Methods based on the detection of rad51 foci in tumor cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6037125A (en) *	1996-11-05	2000-03-14	Lexicon Genetics Incorporated	Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells
WO1998034118A1 (en) *	1997-01-30	1998-08-06	Yale University	Diagnostic methods and compositions based on the distribution of rad51

2000
- 2000-08-10 AU AU67673/00A patent/AU6767300A/en not_active Abandoned
- 2000-08-10 EP EP00955469A patent/EP1204868A1/en not_active Withdrawn
- 2000-08-10 WO PCT/US2000/022077 patent/WO2001011369A1/en not_active Ceased
- 2000-08-10 CA CA002379608A patent/CA2379608A1/en not_active Abandoned
- 2000-08-10 JP JP2001515973A patent/JP2003506100A/en active Pending

Also Published As

Publication number	Publication date
EP1204868A1 (en)	2002-05-15
WO2001011369A8 (en)	2001-04-05
CA2379608A1 (en)	2001-02-15
WO2001011369A1 (en)	2001-02-15
JP2003506100A (en)	2003-02-18

Publication	Publication Date	Title
AU8026600A (en)	2001-04-30	Brachytherapy instrument and methods
AU6528800A (en)	2001-04-24	Methods and apparatuses for radiation treatment
AU2001290891A1 (en)	2002-03-26	Frameless radiosurgery treatment system and method
AU2001255655A1 (en)	2001-11-07	Treatment analysis systems and methods
AU2513400A (en)	2000-08-25	Authentication system and process
AU3729400A (en)	2000-09-28	Medical grafting methods and apparatus
AU1808101A (en)	2001-06-12	Medical grafting methods and apparatus
AU4052897A (en)	1998-03-19	Cancer treatment method
AU5317500A (en)	2000-12-28	Medical grafting apparatus and methods
AU2002237774A1 (en)	2002-07-24	Latch apparatus and method
AU715620C (en)	2001-11-22	Therapeutic methods and uses
AU1250401A (en)	2001-04-10	Door construction and method
AU1594701A (en)	2001-06-04	Stereotactic apparatus and methods
AU2001287890A1 (en)	2002-04-22	Radiotherapy apparatus and collimator set therefor
AU7856100A (en)	2001-05-10	Methods for treating solid tumors with irradiation and bacteria
AU6767300A (en)	2001-03-05	Cancer treatments and diagnostics utilizing rad51 related molecules and methods
AU7491700A (en)	2001-04-17	Shopping list organizer apparatus and method
AU1083501A (en)	2001-04-23	Antibiotic-metal complex and methods
AU2002227247A1 (en)	2002-06-18	Biofilm therapy process and elements
AU2002227148A1 (en)	2002-05-06	Latch apparatus and method
AU2002305138A1 (en)	2002-10-21	Methods and materials for cancer treatment
AU6014400A (en)	2001-02-13	Treating device and treating method
AU5316099A (en)	2000-02-07	Prostate cancer assays and related methods
AU5097099A (en)	2000-02-07	Methods and compositions for cancer treatment
AU2616201A (en)	2001-04-30	Cancer treatment method

Legal Events

Date	Code	Title	Description
2002-05-02	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase